{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:38:20Z","timestamp":1790797100780,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","award":["007491"],"award-info":[{"award-number":["007491"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/NEU-BEN\/0156\/2012"],"award-info":[{"award-number":["PTDC\/NEU-BEN\/0156\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/Multi \/00709\/2013"],"award-info":[{"award-number":["UID\/Multi \/00709\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbi.2017.04.016","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T06:31:05Z","timestamp":1493015465000},"page":"296-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment"],"prefix":"10.1016","volume":"64","author":[{"given":"Julieta","family":"Mendes-Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Lopes Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Alexandra","family":"Videira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u00e7a","family":"Baltazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2017.04.016_b0005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1471-4159.2010.07151.x","article-title":"Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons","volume":"116","author":"Aumann","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2017.04.016_b0010","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.lfs.2011.03.010","article-title":"The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson\u2019s disease","volume":"88","author":"Baraka","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.bbi.2017.04.016_b0015","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.bbadis.2015.07.004","article-title":"GPER: a new tool to protect dopaminergic neurons?","volume":"1852","author":"Bessa","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbi.2017.04.016_b0020","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1046\/j.1471-4159.1995.64041669.x","article-title":"Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain","volume":"64","author":"Blanchard","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2017.04.016_b0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneuroim.2009.06.023","article-title":"Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis","volume":"214","author":"Blasko","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2017.04.016_b0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability","volume":"8","author":"Blesa","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.bbi.2017.04.016_b0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2017.04.016_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nchembio775","article-title":"Virtual and biomolecular screening converge on a selective agonist for GPR30","volume":"2","author":"Bologa","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbi.2017.04.016_b0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.yfrne.2012.02.003","article-title":"Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson\u2019s disease","volume":"33","author":"Bourque","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.bbi.2017.04.016_b0050","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neurobiolaging.2012.05.022","article-title":"Implication of GPER1 in neuroprotection in a mouse model of Parkinson\u2019s disease","volume":"34","author":"Bourque","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2017.04.016_b0055","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1210\/en.2010-0371","article-title":"Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta","volume":"151","author":"Brown","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbi.2017.04.016_b0060","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1210\/endo.141.10.7693","article-title":"Antiinflammatory effects of estrogen on microglial activation","volume":"141","author":"Bruce-Keller","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbi.2017.04.016_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.0022-3042.2001.00693.x","article-title":"Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture","volume":"80","author":"Callier","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2017.04.016_b0070","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1365-2826.2012.02348.x","article-title":"GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones","volume":"24","author":"Campos","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bbi.2017.04.016_b0075","doi-asserted-by":"crossref","first-page":"e5482","DOI":"10.1371\/journal.pone.0005482","article-title":"Striatal neuroinflammation promotes Parkinsonism in rats","volume":"4","author":"Choi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2017.04.016_b0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/syn.10145","article-title":"Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice","volume":"47","author":"D'Astous","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.bbi.2017.04.016_b0085","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","article-title":"Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson\u2019s disease","volume":"81","author":"Gao","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2017.04.016_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.02.032","article-title":"Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide","volume":"1084","author":"Gibbons","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2017.04.016_b0095","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","article-title":"Gender differences in Parkinson\u2019s disease","volume":"78","author":"Haaxma","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbi.2017.04.016_b0100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/nbdi.2000.0289","article-title":"The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system","volume":"7","author":"Herrera","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2017.04.016_b0105","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1523\/JNEUROSCI.18-15-05614.1998","article-title":"Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease","volume":"18","author":"Ho","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.04.016_b0110","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/jnr.22012","article-title":"Intrastriatal lipopolysaccharide injection induces parkinsonism in C57\/B6 mice","volume":"87","author":"Hunter","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2017.04.016_b0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2017.04.016_b0120","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","article-title":"Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia","volume":"20","author":"Kim","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.04.016_b0125","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2017.04.016_b0130","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/brain\/awn085","article-title":"Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia","volume":"131","author":"Lee","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2017.04.016_b0135","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2017.04.016_b0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/jnr.20583","article-title":"Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia","volume":"81","author":"Liu","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2017.04.016_b0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2010.10.002","article-title":"Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation","volume":"60","author":"Liu","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2017.04.016_b0150","doi-asserted-by":"crossref","first-page":"15720","DOI":"10.1038\/srep15720","article-title":"Tiagabine protects dopaminergic neurons against neurotoxins by inhibiting microglial activation","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2017.04.016_b0155","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbi.2017.04.016_b0160","first-page":"118","article-title":"Gender differences in Parkinson\u2019s disease","volume":"21","author":"Lyons","year":"1998","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.bbi.2017.04.016_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020151","article-title":"Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of Parkinson\u2019s disease-lessons from transgenic mice","volume":"17","author":"Machado","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2017.04.016_b0170","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mds.26579","article-title":"How compensation breaks down in Parkinson\u2019s disease: insights from modeling of denervated striatum","volume":"31","author":"Navntoft","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2017.04.016_b0175","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1210\/en.2008-0269","article-title":"G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol","volume":"149","author":"Otto","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbi.2017.04.016_b0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1095\/biolreprod.108.071175","article-title":"GPR30 does not mediate estrogenic responses in reproductive organs in mice","volume":"80","author":"Otto","year":"2009","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.bbi.2017.04.016_b0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2017.04.016_b0190","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1523\/JNEUROSCI.21-14-05147.2001","article-title":"The role of dopamine receptors in regulating the size of axonal arbors","volume":"21","author":"Parish","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.04.016_b0195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2017.04.016_b0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000070277","article-title":"Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice","volume":"77","author":"Ramirez","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bbi.2017.04.016_b0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2010.07.017","article-title":"GPR30\/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages","volume":"328","author":"Rettew","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbi.2017.04.016_b0210","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1523\/JNEUROSCI.14-05-02687.1994","article-title":"Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system","volume":"14","author":"Robinson","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.04.016_b0215","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jnr.1149","article-title":"Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism","volume":"65","author":"Rothblat","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2017.04.016_b0220","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0028-3908(02)00049-7","article-title":"Estradiol protects dopaminergic neurons in a MPP+Parkinson\u2019s disease model","volume":"42","author":"Sawada","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2017.04.016_b0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuint.2015.06.004","article-title":"Characterization of the lipopolysaccharide induced model of Parkinson\u2019s disease: role of oxidative stress and neuroinflammation","volume":"87","author":"Sharma","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbi.2017.04.016_b0230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/14737175.6.3.407","article-title":"Gender disparities in Parkinson\u2019s disease","volume":"6","author":"Shulman","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbi.2017.04.016_b0235","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s11064-010-0336-7","article-title":"Estrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and death","volume":"36","author":"Smith","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbi.2017.04.016_b0240","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0022-3565(25)13058-9","article-title":"Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals","volume":"253","author":"Snyder","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2017.04.016_b0245","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1523\/JNEUROSCI.20-13-05102.2000","article-title":"Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting","volume":"20","author":"Song","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.04.016_b0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1742-2094-10-143","article-title":"Activation of microglia induces symptoms of Parkinson\u2019s disease in wild-type, but not in IL-1 knockout mice","volume":"10","author":"Tanaka","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2017.04.016_b0255","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0968051907080428","article-title":"Effects of estrogen against LPS-induced inflammation and toxicity in primary rat glial and neuronal cultures","volume":"13","author":"Tenenbaum","year":"2007","journal-title":"J. Endotoxin. Res."},{"key":"10.1016\/j.bbi.2017.04.016_b0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2006.02.029","article-title":"Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication","volume":"1084","author":"Tripanichkul","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2017.04.016_b0265","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbi.2017.04.016_b0270","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1523\/JNEUROSCI.21-06-01809.2001","article-title":"Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia","volume":"21","author":"Vegeto","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2017.04.016_b0275","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1210\/en.2005-1330","article-title":"The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation","volume":"147","author":"Vegeto","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbi.2017.04.016_b0280","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2172-11-20","article-title":"GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol","volume":"11","author":"Yates","year":"2010","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bbi.2017.04.016_b0285","doi-asserted-by":"crossref","first-page":"e00449","DOI":"10.1002\/brb3.449","article-title":"GPER expressed on microglia mediates the anti-inflammatory effect of estradiol in ischemic stroke","volume":"6","author":"Zhao","year":"2016","journal-title":"Brain Behav."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117301265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117301265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T21:31:00Z","timestamp":1740432660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159117301265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":57,"alternative-id":["S0889159117301265"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2017.04.016","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2017.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}